Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
Bites from elapid snakes typically result in neurotoxic symptoms in snakebite victims. Neurotoxins are, therefore, often the focus of research relating to understanding the pathogenesis of elapid bites. However, recent evidence suggests that some elapid snake venoms contain anticoagulant toxins whic...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/13/5/302 |
id |
doaj-db8d99bd5e744e5c9a2b7c1cbd303297 |
---|---|
record_format |
Article |
spelling |
doaj-db8d99bd5e744e5c9a2b7c1cbd3032972021-04-23T23:06:39ZengMDPI AGToxins2072-66512021-04-011330230210.3390/toxins13050302Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by VarespladibTaline D. Kazandjian0Arif Arrahman1Kristina B.M. Still2Govert W. Somsen3Freek J. Vonk4Nicholas R. Casewell5Mark C. Wilkinson6Jeroen Kool7Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKDepartment of Chemistry and Pharmaceutical Sciences, Division of Bioanalytical Chemistry, Faculty of Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The NetherlandsDepartment of Chemistry and Pharmaceutical Sciences, Division of Bioanalytical Chemistry, Faculty of Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The NetherlandsDepartment of Chemistry and Pharmaceutical Sciences, Division of Bioanalytical Chemistry, Faculty of Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The NetherlandsNaturalis Biodiversity Center, Darwinweg 2, 2333CR Leiden, The NetherlandsCentre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKCentre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKDepartment of Chemistry and Pharmaceutical Sciences, Division of Bioanalytical Chemistry, Faculty of Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The NetherlandsBites from elapid snakes typically result in neurotoxic symptoms in snakebite victims. Neurotoxins are, therefore, often the focus of research relating to understanding the pathogenesis of elapid bites. However, recent evidence suggests that some elapid snake venoms contain anticoagulant toxins which may help neurotoxic components spread more rapidly. This study examines the effects of venom from the West African black-necked spitting cobra (<i>Naja nigricollis</i>) on blood coagulation and identifies potential coagulopathic toxins. An integrated RPLC-MS methodology, coupled with nanofractionation, was first used to separate venom components, followed by MS, proteomics and coagulopathic bioassays. Coagulation assays were performed on both crude and nanofractionated <i>N. nigricollis</i> venom toxins as well as PLA<sub>2</sub>s and 3FTx purified from the venom. Assays were then repeated with the addition of either the phospholipase A<sub>2</sub> inhibitor varespladib or the snake venom metalloproteinase inhibitor marimastat to assess whether either toxin inhibitor is capable of neutralizing coagulopathic venom activity. Subsequent proteomic analysis was performed on nanofractionated bioactive venom toxins using tryptic digestion followed by nanoLC-MS/MS measurements, which were then identified using Swiss-Prot and species-specific database searches. Varespladib, but not marimastat, was found to significantly reduce the anticoagulant activity of <i>N. nigricollis</i> venom and MS and proteomics analyses confirmed that the anticoagulant venom components mostly consisted of PLA<sub>2</sub> proteins. We, therefore, conclude that PLA<sub>2</sub>s are the most likely candidates responsible for anticoagulant effects stimulated by <i>N. nigricollis</i> venom.https://www.mdpi.com/2072-6651/13/5/302snakebite<i>Naja nigricollis</i>coagulopathyvarespladibmarimastatnanofractionation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Taline D. Kazandjian Arif Arrahman Kristina B.M. Still Govert W. Somsen Freek J. Vonk Nicholas R. Casewell Mark C. Wilkinson Jeroen Kool |
spellingShingle |
Taline D. Kazandjian Arif Arrahman Kristina B.M. Still Govert W. Somsen Freek J. Vonk Nicholas R. Casewell Mark C. Wilkinson Jeroen Kool Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib Toxins snakebite <i>Naja nigricollis</i> coagulopathy varespladib marimastat nanofractionation |
author_facet |
Taline D. Kazandjian Arif Arrahman Kristina B.M. Still Govert W. Somsen Freek J. Vonk Nicholas R. Casewell Mark C. Wilkinson Jeroen Kool |
author_sort |
Taline D. Kazandjian |
title |
Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib |
title_short |
Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib |
title_full |
Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib |
title_fullStr |
Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib |
title_full_unstemmed |
Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib |
title_sort |
anticoagulant activity of <i>naja nigricollis</i> venom is mediated by phospholipase a2 toxins and inhibited by varespladib |
publisher |
MDPI AG |
series |
Toxins |
issn |
2072-6651 |
publishDate |
2021-04-01 |
description |
Bites from elapid snakes typically result in neurotoxic symptoms in snakebite victims. Neurotoxins are, therefore, often the focus of research relating to understanding the pathogenesis of elapid bites. However, recent evidence suggests that some elapid snake venoms contain anticoagulant toxins which may help neurotoxic components spread more rapidly. This study examines the effects of venom from the West African black-necked spitting cobra (<i>Naja nigricollis</i>) on blood coagulation and identifies potential coagulopathic toxins. An integrated RPLC-MS methodology, coupled with nanofractionation, was first used to separate venom components, followed by MS, proteomics and coagulopathic bioassays. Coagulation assays were performed on both crude and nanofractionated <i>N. nigricollis</i> venom toxins as well as PLA<sub>2</sub>s and 3FTx purified from the venom. Assays were then repeated with the addition of either the phospholipase A<sub>2</sub> inhibitor varespladib or the snake venom metalloproteinase inhibitor marimastat to assess whether either toxin inhibitor is capable of neutralizing coagulopathic venom activity. Subsequent proteomic analysis was performed on nanofractionated bioactive venom toxins using tryptic digestion followed by nanoLC-MS/MS measurements, which were then identified using Swiss-Prot and species-specific database searches. Varespladib, but not marimastat, was found to significantly reduce the anticoagulant activity of <i>N. nigricollis</i> venom and MS and proteomics analyses confirmed that the anticoagulant venom components mostly consisted of PLA<sub>2</sub> proteins. We, therefore, conclude that PLA<sub>2</sub>s are the most likely candidates responsible for anticoagulant effects stimulated by <i>N. nigricollis</i> venom. |
topic |
snakebite <i>Naja nigricollis</i> coagulopathy varespladib marimastat nanofractionation |
url |
https://www.mdpi.com/2072-6651/13/5/302 |
work_keys_str_mv |
AT talinedkazandjian anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib AT arifarrahman anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib AT kristinabmstill anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib AT govertwsomsen anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib AT freekjvonk anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib AT nicholasrcasewell anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib AT markcwilkinson anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib AT jeroenkool anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib |
_version_ |
1721512106191224832 |